These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 21821519)
41. Potential Clinical Implications of miR-1 and miR-21 in Heart Disease and Cardioprotection. Kura B; Kalocayova B; Devaux Y; Bartekova M Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31973111 [TBL] [Abstract][Full Text] [Related]
42. From the National Heart, Lung, and Blood Institute (NHLBI): benefits of quitting smoking outpace risk of modest weight gain. National Heart, Lung, and Blood Institute Ethn Dis; 2013; 23(3):387. PubMed ID: 23914431 [No Abstract] [Full Text] [Related]
43. Role of antiplatelet agents in cardioprotection. Cohn PF Am J Manag Care; 2002 Jun; 8(9 Suppl):38-9. PubMed ID: 12099327 [No Abstract] [Full Text] [Related]
44. [Rational use of inotropic sympathomimetic amines in resuscitation]. Richard C; Berdeaux A Rev Prat; 1985 Jun; 35(35):2123-30. PubMed ID: 4048795 [No Abstract] [Full Text] [Related]
45. Pulseless electric activity: definition, causes, mechanisms, management, and research priorities for the next decade: report from a National Heart, Lung, and Blood Institute workshop. Myerburg RJ; Halperin H; Egan DA; Boineau R; Chugh SS; Gillis AM; Goldhaber JI; Lathrop DA; Liu P; Niemann JT; Ornato JP; Sopko G; Van Eyk JE; Walcott GP; Weisfeldt ML; Wright JD; Zipes DP Circulation; 2013 Dec; 128(23):2532-41. PubMed ID: 24297818 [No Abstract] [Full Text] [Related]
46. Metabolic syndrome in Argentine women: ATPIII, IDF, IDF/AHA/NHLBI; what criterion should be used? Soutelo J; Saban M; Quevedo V; Gandur E; Paris A; Alba P; Gonzalez J; Barbero M; Frizt C; Faraj G Gynecol Endocrinol; 2011 Jun; 27(6):448-51. PubMed ID: 20670098 [TBL] [Abstract][Full Text] [Related]
47. Pharmacotherapy of congestive heart failure: pimobendan, a new approach to inotropic stimulation. Proceedings of a satellite symposium to the Xth European Congress of Cardiology. Vienna, Austria, August 31, 1988. J Cardiovasc Pharmacol; 1989; 14 Suppl 2():S1-64. PubMed ID: 2478785 [No Abstract] [Full Text] [Related]
49. [Natriuretic peptides: anything new in cardiology?]. Malinowski M; Biernat J; Roleder T; Dalecka AM; Reszka B; Deja MA; Wośf S; Gołba KS Kardiol Pol; 2006 Oct; 64(10 Suppl 6):S578-85. PubMed ID: 20527380 [TBL] [Abstract][Full Text] [Related]
50. A Scientist-Skeptic-Agnostic's View of the Church of Anesthetic Cardioprotection. Pagel PS J Cardiothorac Vasc Anesth; 2015 Dec; 29(6):e77-8. PubMed ID: 26601575 [No Abstract] [Full Text] [Related]
51. National Heart, Lung, and Blood Institute cardiovascular clinical trial perspective. Pearson GD; Mensah GA; Rosenberg Y; Stoney CM; Kavounis K; Goff DC Am Heart J; 2020 Jun; 224():25-34. PubMed ID: 32298849 [TBL] [Abstract][Full Text] [Related]
52. Why research on resveratrol-mediated cardioprotection should not decelerate. Netticadan T Can J Physiol Pharmacol; 2012 May; 90(5):iii-vi. PubMed ID: 22548503 [No Abstract] [Full Text] [Related]
53. Harnessing the Power of Integrated Mitochondrial Biology and Physiology: A Special Report on the NHLBI Mitochondria in Heart Diseases Initiative. Ping P; Gustafsson ÅB; Bers DM; Blatter LA; Cai H; Jahangir A; Kelly D; Muoio D; O'Rourke B; Rabinovitch P; Trayanova N; Van Eyk J; Weiss JN; Wong R; Schwartz Longacre L Circ Res; 2015 Jul; 117(3):234-8. PubMed ID: 26185209 [TBL] [Abstract][Full Text] [Related]
54. Future Directions and Resource Needs for National Heart, Lung, and Blood Institute (NHLBI) Gene Therapy Research: A Report of an NHLBI Workshop. McDonald CL; Qasba P; Anderson DG; Bao G; Colvin RA; Kohn DB; Malik P; Mitchell MJ; Pu WT; Rawlings DJ; Williams DA; Flotte TR Hum Gene Ther; 2023 Feb; 34(3-4):83-89. PubMed ID: 36794978 [No Abstract] [Full Text] [Related]
55. Future Research Directions in Asthma. An NHLBI Working Group Report. Levy BD; Noel PJ; Freemer MM; Cloutier MM; Georas SN; Jarjour NN; Ober C; Woodruff PG; Barnes KC; Bender BG; Camargo CA; Chupp GL; Denlinger LC; Fahy JV; Fitzpatrick AM; Fuhlbrigge A; Gaston BM; Hartert TV; Kolls JK; Lynch SV; Moore WC; Morgan WJ; Nadeau KC; Ownby DR; Solway J; Szefler SJ; Wenzel SE; Wright RJ; Smith RA; Erzurum SC Am J Respir Crit Care Med; 2015 Dec; 192(11):1366-72. PubMed ID: 26305520 [TBL] [Abstract][Full Text] [Related]
56. Melatonin and myocardial protection. Lavi R; Lavi S Int J Cardiol; 2011 Jul; 150(2):207. PubMed ID: 21592602 [No Abstract] [Full Text] [Related]
57. Update on cardiac drugs: inotropic and chronotropic agents. Mutnick AH; Fecitt S; Rogers B Nursing; 1987 Oct; 17(10):58-61. PubMed ID: 3658258 [No Abstract] [Full Text] [Related]